AbbVie Inc.:企業の戦略・SWOT・財務分析

【英語タイトル】AbbVie Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(MLINE7090045)・商品コード:MLINE7090045
・発行会社(調査会社):MarketLine
・発行日:2017年1月31日
・ページ数:55
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥19,425見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD350 ⇒換算¥38,850見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD525 ⇒換算¥58,275見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

SummaryAbbVie Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Findings
- Detailed information on AbbVie Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis
- An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments
- Intelligence on AbbVie Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AbbVie Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy
- Gain understanding of AbbVie Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AbbVie Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AbbVie Inc.’s business structure, strategy and prospects.

Key Highlights
AbbVie Inc. (AbbVie or ‘the company’) is a research-based biopharmaceutical company. The company primarily operates in the US, Canada, Mexico, European Union, Japan and Brazil. It is headquartered in North Chicago, Illinois.

【レポートの目次】

Company Snapshot
AbbVie Inc.: Company Overview
AbbVie Inc.: Overview and Key Facts
AbbVie Inc.: Overview
AbbVie Inc.: Key Facts
AbbVie Inc.: Key Employees
AbbVie Inc.: Key Employee Biographies
AbbVie Inc.: Major Products and Services
AbbVie Inc.: Company History
AbbVie Inc.: Management Statement
AbbVie Inc.: Locations and Subsidiaries
AbbVie Inc.: Key Competitors
AbbVie Inc.: Company Analysis
AbbVie Inc.: Business Description
AbbVie Inc.: SWOT Analysis
AbbVie Inc.: SWOT Overview
AbbVie Inc.: Strengths
AbbVie Inc.: Weaknesses
AbbVie Inc.: Opportunities
AbbVie Inc.: Threats
AbbVie Inc.: Corporate Financial Deals Activity
AbbVie Inc.: Financial Deals Overview
AbbVie Inc.: Targets and Partners
AbbVie Inc.: Top Deals 2013 – 2017YTD*
AbbVie Inc.: Advisors
AbbVie Inc.: Top Legal Advisors
AbbVie Inc.: Mergers and Acquisitions
AbbVie Inc.: Corporate Venturing
AbbVie Inc.: Partnership
AbbVie Inc.: Recent Developments
AbbVie Inc.: News and Events Summary
AbbVie Inc.: Contracts
AbbVie Inc.: Financial Deals
AbbVie Inc.: Financial Performance
AbbVie Inc.: Regulatory and Legal Events
AbbVie Inc.: Research and Development
AbbVie Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

Table 1: AbbVie Inc.: Key Facts
Table 2: AbbVie Inc.: Key Employees
Table 4: AbbVie Inc.: Key Competitors
Table 5: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: AbbVie Inc.: MandA Activity by Geography (TTM*)
Table 7: AbbVie Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: AbbVie Inc.: MandA Average Deal Size - Value (US$m)
Table 9: AbbVie Inc.: Targets and Partners
Table 10: AbbVie Inc.: Top Deals 2013 - 2017YTD*
Table 11: AbbVie Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: AbbVie Inc.: MandA Volume and Value Trend (2013 - YTD*2017)
Table 13: AbbVie Inc.: MandA Activity by Geography (2013 - YTD*2017)
Table 14: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 15: AbbVie Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 16: AbbVie Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 17: AbbVie Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 18: AbbVie Inc.: News and Events Summary
Table 19: AbbVie Inc.: Contracts
Table 20: AbbVie Inc.: Financial Deals
Table 21: AbbVie Inc.: Financial Performance
Table 22: AbbVie Inc.: Regulatory and Legal Events
Table 23: AbbVie Inc.: Research and Development
Table 24: AbbVie Inc.: Strategy and Operations

Figure 1: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AbbVie Inc.: MandA Activity by Geography (TTM*)
Figure 3: AbbVie Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Figure 4: AbbVie Inc.: MandA Average Deal Size - Value (US$m)
Figure 5: AbbVie Inc.: MandA Volume and Value Trend (2013 - YTD*2017)
Figure 6: AbbVie Inc.: MandA Activity by Geography (2013 - YTD*2017)
Figure 7: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Figure 8: AbbVie Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Figure 9: AbbVie Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Figure 10: AbbVie Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)

★調査レポート[AbbVie Inc.:企業の戦略・SWOT・財務分析] (コード:MLINE7090045)販売に関する免責事項を必ずご確認ください。
★調査レポート[AbbVie Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆